eFFECTOR Therapeutics

-$0.01 (-0.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EFTR and other ETFs, options, and stocks.

About EFTR

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2).

CEO
Stephen T. Worland
Employees
13
Headquarters
Solana Beach, California
Founded
2012

EFTR Key Statistics

Market cap
70.79M
Price-Earnings ratio
3.09
Dividend yield
—
Average volume
30.95K
High today
$1.90
Low today
$1.71
Open price
$1.90
Volume
9.88K
52 Week high
$40.42
52 Week low
$1.63

EFTR Earnings

-$0.25
-$0.02
$0.21
$0.44
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.24 per share
Actual
$0.07 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure